Lung cancer comes in two main types: non-small cell and small cell. Each has different patterns, growth rates, and treatment needs. Smoking is the top risk factor, but…
Harry Erba, MD, PhD, Duke University, Durham, NC; Marina Konopleva, MD, PhD, Albert Einstein College of Medicine, New York City, NY; Thomas Cluzeau, MD, PhD, Central University Hospital…
NEW YORK (Reuters Health) – Intravenous immunoglobulin (IVIG) offers advantages over plasma exchange (PLEX) for many patients with myasthenia gravis, according to a report online in the November…
NEW YORK (Reuters Health) – In boys with nonpalpable cryptorchidism, performing ultrasound before surgery to localize the testes is not necessary and shouldn’t be done, two urologists from…
NEW YORK (Reuters Health) – A UK national audit shows that in chronic obstructive pulmonary disease (COPD), non-invasive ventilation (NIV) is often used – or not used –…
NEW YORK (Reuters Health) – A study of Chernobyl survivors shows no difference in recurrence patterns between radiation-related and sporadic thyroid cancers. “Similar treatment approaches should be recommended…
NEW YORK (Reuters Health) – Although large pupil size is viewed by some ophthalmologists as a relative contraindication to undergoing LASIK, preoperative pupil size does not affect quality…
NEW YORK (Reuters Health) – Hypothermia and the medications used with it can influence the common predictors of neurologic outcome after cardiac arrest, according to findings published online…
NEW YORK (Reuters Health) – In a retrospective study of patients with severe sepsis or septic shock, those who received a single-dose of etomidate before rapid sequence intubation…
NEW YORK (Reuters Health) – In a prospective study, the beta-1 selective blocker bisoprolol proved more effective than the non-selective beta-blocker carvedilol in preventing atrial fibrillation after coronary…
NEW YORK (Reuters Health) – Smoking does not affect outcomes after early clopidogrel use in patients with acute coronary syndrome (ACS), according to findings published in the November…
NEW YORK (Reuters Health) – Patients with generalized anxiety disorder (GAD) are best treated with an antidepressant for at least 12 months, according to a study published in…
